Transcarent Stock

transcarent.aiHealthcare / Healthcare providers & servicesFounded: 2018Funding to Date: $454.37MM

Transcarent is a health experience company combining software, technology, data science and health guides to empower consumers with the kind of unbiased information, trusted guidance and access to high-value care that leads to better care, better outcomes, and more cost-effective decisions and allows Members to share in the benefits of their decisions.

Register To Buy and Sell Shares

For more details on financing and valuation for Transcarent, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value

Powered by Forge Data

Access Transcarent’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Transcarent.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Register

Animation displayed is not current and securities are shown for illustrative purposes only.

Frequently Asked Questions About Transcarent’s Stock

plusminus
Can you buy Transcarent’s stock?
Transcarent is not publicly traded on NYSE or NASDAQ in the U.S. To buy Transcarent’s stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
plusminus
Can you sell Transcarent’s stock?
Yes, you can sell stock of a private company like Transcarent. Forge can help you sell your Transcarent stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
plusminus
What is Transcarent’s stock price?
Transcarent is a privately held company and therefore does not have a public stock price. However, you may access Transcarent’s private market stock price with Forge Data.
plusminus
What is Transcarent’s stock ticker symbol?
Transcarent does not have an official ticker symbol because this company is not currently publicly traded.
plusminus
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

Health Startup Transcarent Is Raising a $125 Million
Transcarent is looking to raise $125 million, bringing its valuation to $2.1 billion.
Trans healthcare startup Plume lays off dozens of workers
Plume, a US-based telehealth startup focusing on trans healthcare, has reportedly laid off around one-sixth of its workforce. The company raised $24m in a series B funding round last year and offers online healthcare services to transgender patients, a demographic often facing significant healthcare barriers. Despite the layoffs, Plume confirmed it will not scale back its services and plans to expand its fee-for-service offerings.
Transcarent Partners With 10 Health Systems To Launch Provider Network
"Transcarent, a care navigation company, has partnered with 10 health systems to launch a new provider network. The network aims to help employer customers provide affordable, high-quality care to their staff. The health systems in the network include Mount Sinai, Mass General Brigham, and Intermountain Health. Transcarent's platform allows patients to access care online, schedule appointments, arrange home visits from providers, access specialists, and order prescription delivery. The company was last valued at $1.62 billion in 2022.
Updated on: Apr 19, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.